Business Description
Genix Pharmaceuticals Corp
NAICS : 325412
SIC : 3741
ISIN : CA37232A1093
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | -5.86 | |||||
Debt-to-Equity | -0.54 | |||||
Debt-to-EBITDA | -0.2 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -135.24 | |||||
Beneish M-Score | -16.73 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -109.1 | |||||
3-Year EPS without NRI Growth Rate | 15.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
14-Day RSI | 92.84 | |||||
6-1 Month Momentum % | 53.85 | |||||
12-1 Month Momentum % | 33.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.14 | |||||
Quick Ratio | 0.04 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 58546 | |||||
Days Sales Outstanding | 474.5 | |||||
Days Payable | 97820 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -9.77 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 75 | |||||
Operating Margin % | -10325 | |||||
Net Margin % | -99925 | |||||
FCF Margin % | -5066.67 | |||||
ROA % | -417.05 | |||||
ROIC % | -21.94 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.95 | |||||
EV-to-EBITDA | -0.98 | |||||
EV-to-Revenue | 922.5 | |||||
EV-to-FCF | -17.74 | |||||
Earnings Yield (Greenblatt) % | -105.26 | |||||
FCF Yield % | -7.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:GENPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Genix Pharmaceuticals Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.003 | ||
EPS (TTM) ($) | -0.047 | ||
Beta | 5.54 | ||
Volatility % | 132.87 | ||
14-Day RSI | 92.84 | ||
14-Day ATR ($) | 0.000007 | ||
20-Day SMA ($) | 0.04 | ||
12-1 Month Momentum % | 33.33 | ||
52-Week Range ($) | 0.0138 - 0.047 | ||
Shares Outstanding (Mil) | 59.22 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Genix Pharmaceuticals Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Genix Pharmaceuticals Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Genix Pharmaceuticals Corp Frequently Asked Questions
What is Genix Pharmaceuticals Corp(GENPF)'s stock price today?
When is next earnings date of Genix Pharmaceuticals Corp(GENPF)?
Does Genix Pharmaceuticals Corp(GENPF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |